These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8683322)

  • 21. [The place of lymphoscintigraphy in the treatment of malignant melanoma of the skin (author's transl)].
    Munz DL; Altmeyer P; Holzmann H; Encke A; Hör G
    Dtsch Med Wochenschr; 1982 Jan; 107(3):86-91. PubMed ID: 7056162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma.
    Bedrosian I; Scheff AM; Mick R; Callans LS; Bucky LP; Spitz FR; Helsabeck C; Elder DE; Alavi A; Fraker DF; Czerniecki BJ
    J Nucl Med; 1999 Jul; 40(7):1143-8. PubMed ID: 10405134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma.
    Uren RF; Howman-Giles R; Thompson JF; Shaw HM; Quinn MJ; O'Brien CJ; McCarthy WH
    Melanoma Res; 1994 Dec; 4(6):395-9. PubMed ID: 7703720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional visualisation of lymphatic drainage patterns in patients with cutaneous melanoma.
    Reynolds HM; Dunbar PR; Uren RF; Blackett SA; Thompson JF; Smith NP
    Lancet Oncol; 2007 Sep; 8(9):806-12. PubMed ID: 17643351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative cutaneous lymphoscintigraphy in malignant melanoma.
    Lock-Andersen J; Rossing N; Drzewiecki KT
    Cancer; 1989 Jan; 63(1):77-82. PubMed ID: 2910428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].
    Valdés Olmos RA; Jansen L; Muller SH; Hoefnagel CA; Nieweg O
    Rev Esp Med Nucl; 1999; 18(2):111-21. PubMed ID: 10352326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct lymphatic drainage from the skin of the forearm to a supraclavicular node.
    Uren RF; Howman-Giles R; Thompson JF; Quinn MJ
    Clin Nucl Med; 1996 May; 21(5):387-9. PubMed ID: 8732834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous lymphoscintigraphy in malignant melanoma.
    Bennett LR; Lago G
    Semin Nucl Med; 1983 Jan; 13(1):61-9. PubMed ID: 6836319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma.
    Glass EC; Essner R; Morton DL
    J Nucl Med; 1998 Jul; 39(7):1185-90. PubMed ID: 9669391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two phase scintigraphic mapping of lymphatic drainage in cutaneous melanoma using 99mTc-sulfur microcolloid/99mTc antimelanoma antibody.
    Limouris GS; Voliotopoulos V; Kondi-Paphiti A; Stavraka A; Vlahos L
    Anticancer Res; 1997; 17(3B):1667-9. PubMed ID: 9179215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of intradermal lymphoscintigraphy on surgical management of clinical stage I truncal malignant melanoma.
    Kramer EL; Sanger JJ; Golomb F; Kopf AW; Postel A
    J Dermatol Surg Oncol; 1987 May; 13(5):508-15. PubMed ID: 3571689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expanding role of lymphoscintigraphy in the management of cutaneous melanoma. First Place Winner: Conrad Jobst award.
    Norman J; Cruse W; Ruas E; Beatty E; Hymes S; Espinosa C; Clark R; Reintgen D
    Am Surg; 1989 Dec; 55(12):689-94. PubMed ID: 2596765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of sentinel node lymphoscintigraphy in malignant melanoma.
    Yudd AP; Kempf JS; Goydos JS; Stahl TJ; Feinstein RS
    Radiographics; 1999; 19(2):343-53; discussion 354-6. PubMed ID: 10194783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphatic drainage of the skin.
    Uren RF
    Ann Surg Oncol; 2004 Mar; 11(3 Suppl):179S-85S. PubMed ID: 15023748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of lymphoscintigraphy and sentinel node mapping in assessing patient risk in melanoma.
    Essner R
    Semin Oncol; 1997 Feb; 24(1 Suppl 4):S8-10. PubMed ID: 9122735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe.
    Mudun A; Murray DR; Herda SC; Eshima D; Shattuck LA; Vansant JP; Taylor AT; Alazraki NP
    Radiology; 1996 Apr; 199(1):171-5. PubMed ID: 8633142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel lymph node mapping in the management of high risk malignant melanoma.
    Donckier V; Vereecken P; Blocklet D; Laporte M; Velu T; Heenen M; Van Geertruyden J
    Acta Chir Belg; 1999 Dec; 99(6):295-8. PubMed ID: 10674132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis of sentinel lymph node in malignant melanoma: preoperative lymphoscintigraphy and intraoperative gamma probe guidance].
    Dresel S; Weiss M; Heckmann M; Rossmüller B; Konz B; Tatsch K; Hahn K
    Nuklearmedizin; 1998 Aug; 37(5):177-82. PubMed ID: 9728345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of second-tier lymph nodes during preoperative lymphoscintigraphy for melanoma: incidence varies with primary tumor site.
    Uren RF; Howman-Giles RB; Thompson JF
    Ann Surg Oncol; 1998 Sep; 5(6):517-21. PubMed ID: 9754760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.